Latest News

Dec 13, 2007

Health Enhancement Products signs contract with Specialty Nutrition Group, Inc for Re-Branding and Product Marketing of ProAlgaZyme.


Nov 14, 2007

Health Enhancement Products Announced the Long Awaited Discovery of a Class of "Orally Active Agents" in Its Primary Product, ProAlgaZyme


Nov 6, 2007

Health Enhancement Products Reports Results in the Second Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial


Oct 25, 2007

Health Enhancement Products Reports Results in Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial



Health Enhancement Products is a member of these organizations







 
Health Enhancement Products Acquires ReplenTish
Product Line and Related Trademarks


- 18 December 2003, 08:31am ET


TEMPE, Ariz., Dec. 18 /PRNewswire - Health Enhancement Products, Inc. , a fast growing nutraceutical company, has acquired the ReplenTish product line and all related trademarks. This is believed to be the first product that seeks to benefit smokers and secondhand smokers by replenishing the numerous critical vitamins and minerals the body loses when a person smokes cigarettes or inhales smoke as a secondhand smoker. Financial terms of the transaction were not disclosed.

Howard Baer, Chairman and Chief Executive Officer of Health Enhancement Products, Inc., said, "Being an ex-smoker myself, I know first hand that smoking is one of the most harmful habits a person can voluntarily engage in. On top of this, the costs incurred by the healthcare system and passive secondhand smokers are estimated to be $150 billion annually in the U.S. alone. We decided to acquire the ReplenTish product line and related trademarks based on the size of the addressable market worldwide and the compelling need for such a product line. While our goal is to build one of the world's largest, most profitable nutraceutical companies, it is always a big plus when we can improve the quality of people's lives along the way. With ReplenTish, we are confident we can accomplish both objectives."

"ReplenTish is currently available for sale exclusively on our websites http://www.heponline.com/ or http://www.replentish.com/ . We expect to make the product available through prominent national and online retailers over the next few quarters."

Selected statistics underscore the dramatically adverse and costly health effects of smoking (source: The American Legacy Foundation as published on http://www.thetruth.com/ and http://www.americanlegacy.org/ )

  • Smoking-related illness costs the U.S. an estimated $150 billion
    each year.
  • Tobacco kills more Americans than AIDS, drugs, homicides, fires, and
    auto accidents combined.
  • Cigarettes will eventually kill a third of the people who use them.
  • Tobacco companies make a product that kills 1,200 Americans a day.
  • Every year, tobacco-related disease kills over 178,000 women, making it
    the largest preventable cause of death among women in the U.S.
  • Worldwide, tobacco products kill about 4.9 million people a year.
  • About 1 out of every 5 deaths in the US can be attributed to tobacco
    products.
  • Secondhand cigarette smoke kills about 53,000 Americans a year.
    Women who quit smoking at age 35 increase their life expectancy by about
    8 years.
  • Approximately one of every five women in America is a smoker. 23% of all
    adult Americans and 21% of American women are currently smokers.
  • For both men and women, the risk of having a heart attack increases with
    the number of cigarettes smoked.
  • Cigarette smoke contains the radioactive isotope Polonium-210.
  • Heavy smokers (two packs a day) are twice as likely as those who smoke
    half a pack a day to have a stroke.
  • The risk of SIDS (Sudden Infant Death Syndrome) is greater among
    children who are exposed to secondhand smoke. In 2000, more than 2,500
    infants died of SIDS
  • In the first two years of life, children who are exposed to secondhand
    smoke from parental smoking have more than a 50% increased risk of
    getting bronchitis and pneumonia.




About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTC: HEPI) is a nutraceutical company directed specifically at the development and marketing of supplementary health-enhancing products using only pure, all-natural and herbal extracts. In particular, Health Enhancement's products use beneficial herbal extracts, vitamins, minerals, and botanical extracts in varying combinations to address common or specific illnesses.

The Company's sole product is ProAlgaZyme that is produced from an algae grown in 100% distilled water. The algae produces an enzyme as a means of protecting itself from exposure to outside disease and harmful bacteria. The enzyme is then drawn off, filtered, tested and bottled for consumption. Recent clinical trials performed by the Company have indicated that ProAlgaZyme may increase and activate the white blood cells in individuals whose white cells are low or inactive, in effect enhancing the immune system. Heath Enhancements is currently doing internal clinical trials on several illnesses and diseases with ProAlgaZyme, including various types of cancer, HIV/AIDS, diabetes and Chronic Fatigue Syndrome.

ReplenTish is currently available for sale exclusively on
our websites www.heponline.com or www.replentish.com .


CONTACTS:
Health Enhancement Products, Inc.
480-385-3800

This press release may contain forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.


© 2007 HEALTH ENHANCEMENT PRODUCTS INC.
            PRIVACY POLICY           DISCLAIMER 

 

v5Design.Com